Open session of the standing technical committee of the EUFMD- 2004

Page 212

Appendix 31 Epidemiological models for global surveillance of Foot-and-Mouth disease Andrés M. Perez1*, Mark C. Thurmond1, Tim E. Carpenter1, Thomas W. Bates2, Wesley O. Johnson3, Brett A. Melbourne1, Shagufta Aslam1, Rebecca B.Garabed1, Young-ku Choi3, Adam J. Branscum3, Miryam L. Gallego1, and Paul W. Grant1 1

The FMD Modeling and Surveillance Laboratory, Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 2 Lawrence Livermore National Laboratory, Livermore, CA 3 Department of Statistics, University of California, Davis, CA

Abstract: This paper summarizes some of the epidemiological models we have developed to describe the global temporal-spatial distribution and risk of FMD and to identify factors that predict changes in FMD status or movement, as applicable to real-time global FMD surveillance. Regional models focused on the time, space (geographic location), and time-space evolution of FMD in specific countries. Countries being studied include Iran, Pakistan, Afghanistan, Turkey, Nepal, Mongolia, Colombia, Bolivia, and Argentina. Country-specific models were validated using methods of cross-validation and expert opinion, as solicited from veterinarians in each country. The results of risk models are projected to assess when and where FMD can be expected and to forecast globally changing risks of FMD. These models could be applied via an FMD web-portal currently under development for realtime global risk surveillance of FMD to characterize changes in time, place, and transmission of FMD, and to identify new anomalous and unexpected FMD cases or precursor events. Real-time global risk surveillance for FMD, utilizing prediction, forecasting, and anomaly detection models, can improve our awareness and assessment of FMD globally and provide fundamental information to enhance biosecurity in free areas and control strategies in infected areas. Introduction: It is becoming increasingly apparent that, if we are to control and perhaps eradicate FMD on a global scale, a comprehensive understanding of the global distributions and changes in risk and movement of the disease must be developed. Currently, we lack of information relating to where FMD can be expected to be found and the new or emerging risks of FMD world wide. Key goals of our laboratory are to disseminate information on FMD relating to outbreaks and isolates, make available modeled distributions of FMD in regions where the information is uncertain, and project or predict risk of infection in FMD-free areas of the world. In this paper we summarize some of the models and approaches explored by our group in the past year. Methods and Results: BioPortal system: The FMD BioPortal is a web-based system designed for the real-time capture and dissemination of data, diagnostic results, and FMD-related risk information to and from countries, agencies, and laboratories. The aim of the portal is to offer a secure and confidential mechanism for rapid transfer of data, analyses, and maps needed to assess changes in FMD risk for specified geographic locations and times. FMD-related data may be obtained automatically or by ‘hand’ upload from websites of the international organizations, such as OIE, FAO, or the WRLFMD, as well as from individual country or agency databases. The database outputs are reformatted into a standardized structure via a data adapter specific to a particular messaging system. The data can be subjected to a variety of epidemiological and statistical analytic and mapping methods, including spatio-temporal clustering, anomaly detection, and spread or movement prediction. Temporal models: The goal of temporal models is to provide an estimate, during some time i, of the expected number of FMD outbreaks in a given region of the world in time i+1. The mathematical process that best models the time series depends on the behavior of the infectious disease (trend, sporadic, seasonal, annual, and secular cycles). We are currently examining the potential application of different Bayesian models that alternatively use autoregressive, random mixed effects, stochastic processes, or the combination of these models to predict the number of FMD outbreaks in Iran. The number of outbreaks reported by Iran from January 1996 through December 2001 is used to select the model that best fit the distribution of the data, using estimates of the mean absolute prediction error and deviance information criterion. Then the selected model is used to predict the number of outbreaks in Iran for the next year, and the resulting prediction is compared with the actual observed number of outbreaks (as part of validation). 203


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.